UBS AM
DSCI

UBS AM’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

UBS AM’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-227,704
Closed -$1.18M – 2549
2016
Q4 		$1.18M Sell
227,704
-9,246
-4% -$43.5K ﹤0.01% 1489
2016
Q3 		$1.11M Buy
236,950
+37,134
+19% +$173K ﹤0.01% 1648
2016
Q2 		$787K Sell
199,816
-142,623
-42% -$533K ﹤0.01% 1752
2016
Q1 		$1.06M Buy
342,439
+97,380
+40% +$326K ﹤0.01% 1616
2015
Q4 		$1.12M Buy
245,059
+139,579
+132% +$662K ﹤0.01% 1700
2015
Q3 		$497K Buy
105,480
+1,222
+1% +$7.89K ﹤0.01% 2022
2015
Q2 		$746K Sell
104,258
-50,093
-32% -$377K ﹤0.01% 1836
2015
Q1 		$1.31M Sell
154,351
-94,853
-38% -$808K ﹤0.01% 1529
2014
Q4 		$2.32M Sell
249,204
-119,146
-32% -$1.04M ﹤0.01% 1263
2014
Q3 		$3.07M Sell
368,350
-5,812
-2% -$53.8K ﹤0.01% 1159
2014
Q2 		$4.33M Buy
374,162
+114,504
+44% +$1.18M ﹤0.01% 1069
2014
Q1 		$3.29M Buy
259,658
+115,139
+80% +$1.49M ﹤0.01% 1150
2013
Q4 		$1.56M Buy
+144,519
New +$1.68M ﹤0.01% 1346

Other funds holding DSCI

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

UBS AM's DSCI Position: Q1 2017 in Review

UBS AM sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 227,704 shares — an estimated $1.18M sold.

UBS AM first reported a position in DSCI in Q4 2013 and held it in 13 quarters. The position peaked at $4.33M in Q2 2014. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

  • UBS AM reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
  • UBS AM sold 227,704 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $1.18M.
  • UBS AM first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2013 and held it in 13 quarters.
  • UBS AM's Derma Sciences, Inc. Common Stock (DE) position peaked at $4.33M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on UBS AM's 13F filing for Q1 2017, filed 4 May 2017.